Biomarin Pharmaceutical Inc financial data

Symbol
BMRN on Nasdaq
Industry
Pharmaceutical Preparations
Location
105 Digital Drive, Novato, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
Feb 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 360 % +8.87%
Quick Ratio 136 % +19.3%
Debt-to-equity 29.6 % -21.8%
Return On Equity 7.97 % +129%
Return On Assets 6.15 % +144%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 191M shares +0.47%
Common Stock, Shares, Outstanding 191M shares +1.15%
Entity Public Float 8.7B USD -13.9%
Common Stock, Value, Issued 191K USD +1.06%
Weighted Average Number of Shares Outstanding, Basic 190M shares +1.17%
Weighted Average Number of Shares Outstanding, Diluted 197M shares +2.67%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.85B USD +18%
Cost of Revenue 580M USD +9.05%
Research and Development Expense 747M USD +0.06%
Costs and Expenses 2.37B USD +6.1%
Operating Income (Loss) 484M USD +161%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 542M USD +187%
Income Tax Expense (Benefit) 115M USD +449%
Net Income (Loss) Attributable to Parent 427M USD +155%
Earnings Per Share, Basic 2.25 USD/shares +153%
Earnings Per Share, Diluted 2.21 USD/shares +154%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 943M USD +24.9%
Accounts Receivable, after Allowance for Credit Loss, Current 661M USD +4.23%
Inventory, Net 1.23B USD +11.3%
Other Assets, Current 202M USD +42.5%
Assets, Current 3.23B USD +9.35%
Deferred Income Tax Assets, Net 1.49B USD -3.65%
Property, Plant and Equipment, Net 1.04B USD -2.17%
Operating Lease, Right-of-Use Asset 28.7M USD -32.9%
Intangible Assets, Net (Excluding Goodwill) 255M USD -13.4%
Goodwill 196M USD 0%
Other Assets, Noncurrent 251M USD +46.6%
Assets 6.99B USD +2.15%
Employee-related Liabilities, Current 203M USD +0.72%
Contract with Customer, Liability, Current 1.37M USD -70.4%
Liabilities, Current 607M USD -48.4%
Operating Lease, Liability, Noncurrent 30.5M USD -19.8%
Other Liabilities, Noncurrent 129M USD +7.41%
Liabilities 1.33B USD -29.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 61.7M USD
Retained Earnings (Accumulated Deficit) -195M USD +68.7%
Stockholders' Equity Attributable to Parent 5.66B USD +14.3%
Liabilities and Equity 6.99B USD +2.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 47M USD
Net Cash Provided by (Used in) Financing Activities -42.8M USD -5.03%
Net Cash Provided by (Used in) Investing Activities -14.2M USD +52.6%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 191M shares +1.15%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -8.13M USD +94.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 943M USD +24.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.42M USD -1.18%
Deferred Tax Assets, Valuation Allowance 126M USD +5.94%
Operating Lease, Liability 37.7M USD -19.2%
Depreciation 46.6M USD +15.6%
Payments to Acquire Property, Plant, and Equipment 26.1M USD +6.74%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 517M USD +262%
Lessee, Operating Lease, Liability, to be Paid 46.8M USD -19.9%
Property, Plant and Equipment, Gross 1.93B USD +0.08%
Operating Lease, Liability, Current 7.23M USD -16.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.91M USD -19.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.12M USD -18.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Deferred Income Tax Expense (Benefit) 285K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9.05M USD -22.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.94M USD -12.9%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD -2.31%
Unrecognized Tax Benefits 325M USD +17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.23M USD -11.8%
Amortization of Intangible Assets 43.3M USD -30.5%
Depreciation, Depletion and Amortization 27.4M USD +3.52%
Deferred Tax Assets, Net of Valuation Allowance 1.55B USD -3.94%
Share-based Payment Arrangement, Expense 202M USD -2.67%
Interest Expense 17.2M USD +8.27%